Revenue nearly tripled since 2021, driven by aggressive expansion in medical submarkets including robotic surgery and safe patient handling.

Performance in 2025 was impacted by $6.3 million in labor inefficiencies at the Illinois AJR facility following E-Verify attrition issues, though Q4 saw these costs more than halve compared to Q3.

Strategic shift of production to the Dominican Republic continues to drive profitability, benefiting from a zero-percent effective income tax rate in that jurisdiction.

The company successfully extended and expanded its contract with its largest customer, materially increasing volumes and adding a new program through 2029.

Operational capacity is being aggressively expanded with the leasing of sixth and seventh buildings in the Dominican Republic to support robotic surgery and safe patient handling growth.

Management successfully integrated seven acquisitions completed across 2024 and 2025 while maintaining a disciplined, value-add approach to M&A.

Guidance for 2026 assumes robust growth in patient services and the ramp-up of three newly launched programs in infection prevention and robotic surgery.

Labor-related headwinds at the AJR facility are expected to diminish sequentially throughout 2026 as temporary staff transition to permanent, higher-skilled roles.

The company expects to work down a significant revenue backlog in the safe patient handling business gradually throughout the 2026 fiscal year.

A CEO transition is finalized for June 2026, with the current CEO moving to Executive Chair for one year to oversee M&A and strategic hires.

Future margin expansion is predicated on the transfer of a third major program to the Dominican Republic, scheduled for the second half of 2026.

A February 2026 ransomware attack resulted in data destruction, but robust backup systems and a contingency plan allowed manufacturing to continue with minimal interruptions to operations.

The effective tax rate dropped to 17.2% due to the structural shift of pre-tax income to tax-exempt operations in the Dominican Republic.

New contract terms include volume-based pricing matrices and cost-sharing provisions between UFP, customers, and vendors to manage long-term inflationary or efficiency shifts.

The company maintains a strong balance sheet with a 1.1x leverage ratio after paying down $53.9 million in debt during 2025.

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.

Management declined to provide specific numerical guidance due to customer confidentiality but confirmed the increase in volume is 'material' compared to previous levels.

Confirmed that historical minimums were in the 'low sevens' and the customer has consistently exceeded those requirements.

Staffing levels have returned to required targets, and the focus has shifted from hiring to training and transitioning temporary workers to permanent status.

Overtime is currently being utilized to clear a backlog that is higher than the previously reported $8 million; this is expected to normalize throughout 2026.

Management expects the impact to be contained within Q1, with February softness likely offset by a recovery in March as ERP systems return to full functionality.

The company utilized a manual contingency plan to maintain production, ensuring no material long-term disruption to customer supply.

UFP's primary financial responsibilities for the new buildings relate to leases and personnel, while customers often co-invest or cover the full cost of specialized capital equipment.

Possession of the sixth building is slated for April, with clean room installations and capacity ramping up later in the year.

One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here.